Although xerostomia is associa ted with aging, studies have dete rmined that salivary gland f unction is well preserved in the healthy geriatric population. Theref ore, dry mouth is probably not a condition ofaging, but most likely one ofsystemic or extrinsic origin. Saliva seems to undergo chemical changes with aging. As the amount of ptyalin decreases and mucin increases, saliva can become thick and viscous and prese nt problems fo r the elderly.
Introduction
Water, water, eve rywhe re, and all the boards did shrink; Water, water, everywhere, nor any drop to drink. Xerostomi a (the term originated in ancient Greece) is a frequ ent and ofte n frustrating complaint handled by the otolaryngolog ist. Th is condition is usuall y asso cia ted with the elderly patient, and it ca n occur in asso ciation with depression , muc ositis, oral and dent al infecti ons, dysph agia , speech disorde rs, and digesti ve probl em s.
It is impo rtant for the astute clinician to sea rch for an underl ying sys temic or extrinsic cau se of xerostomia. Th ese ca n includ e met aboli c or immune conditions, medication use, and/or a history of radio the rapy to the head or nec k. Head and neck spec ialists can gre atly ser ve their patient s with dr y mouth syndrome by taking the time to inqu ire about their ge nera l state of health in a sensitive and empathic manner. Even though xerostomia remain s difficult to treat, there are therap euti c strategies that can greatly imp rove the patient ' s well-bein g and prevent further complications.
Salivary physiology
Sal iva contains proteins, glycoprotei ns, enzy mes, electrolytes, and small orga nic molecules in a secretion that maintains oral homeostasis.' Sali va sec retion is the result of cholin ergic stimulation of musca rinic receptors within the saliva ry glands. The healthy adult produces approximately 1.5 L of saliv a every 24 hours. Normal patient s produc e app roximatel y 0.4 ml of saliv a per minute . When stimulated, the saliv ary glands are able to produce five tim es as much saliva-about 2 ml/rnin.'
The three major paired sa liva ry glands-the parotid, the sublingual, and the submandibular-produce 90% of . the total salivary output. Min or salivary glands are located throughout the buccal mucosa and palate , and they account for the re mainder of the secretory output. When a person is awake, the parot id glands secre te up to 50 % of the saliva output. But when a person is asleep, the parotid co ntributes alm ost no sa liva; mos t of the noctu rnal output is prov ided by the submandibular glands . The parotid gland secretes mostl y sero us flu id that makes for the watery characteristics of saliva, while the sublingual glands produce mucin, saliva's viscous comp onent. The subman-ENT·Ear, Nose & Throat Journal-July 1999 dibular gland secretes a mixture of serous and mucin .
The function of saliva is as diver se as it is critical. Water and mucin-in addition to enzymes such as amylase, ribonuclease, and lipa se-initiate the digestion of food by lubricating it and dis solving it into particles. Sali va also help s maintain proper oral and uppe r gastrointestinal pH levels, and it modulates the oral flora (many glycoproteins and en zyme s contain antibacterial, antifungal, and antiviral properties). Saliva is also con sidered part of the mucos al immune system , because plasma cell s within the salivary glands produce immunoglobulin A (lgA ) antibodies. The buffering capacity of saliva protects tooth enamel and contributes to dental health. Finally, saliv a is essential for good speech and taste, as previously mentioned.'
Natural aging bring s about significant changes in the composition and mixture of saliva, primarily a decrease in ptyalin and an incre ase in muc in. In the elderly , sali va can become thick and viscous. Although sali vation decreases with aging, it still remains adequate in normal, healthy persons.' .
Prevalence and associated causes
Xero stomia is a subjective complaint, so it might not correlate with actual phy sical finding s of oral dryness. Indeed, an impaired or altered psycho sensory function can affect the perception of oral moisture . Locker studied subjective complaints of oral dryness in an elderly population , and determined that it was reported by almost 20% of those surveyed.' Of the 22 symptoms included in that sur vey, xerostomia was the most common. Locker documented three predictors of oral dryness in this group: the use of prescribed medic ations, recent stress, and the patient' s income. Gilbert et al questioned 600 elderly, community-dwelling Flo rid ians and fou nd that 39% reported expe rienc ing xerostomia." They too concluded that the high prevalence of xerostomia in this popul ation was associated with the use of multiple medications. Locker performed a second study of xerostomia in patient s aged SO and older and identified three predi ctive baseline characteristics: age, chronic medic al conditions, and poor general health ." Navazesh et al reported on the relationship between xero stomia and the patient ' s medic al status, the number of medications, and salivary flow ." They determined that patient s with systemic disorders who took xerogenic medications had significantly lower sali vary flow rate s. In addition, their study docum ented that men have higher overall salivary flow rate s than women. Age did not have any effect on flow rates in the study, confirming findin gs by others.
Common causes and case studies
Th e ca se studies presented here illustr ate three of the Volume 78, Number 7 different cau ses of xerostomia: drug therapy , systemic disea se, and radiation therapy.
Case 1: Drug therapy. Antichol iner gic medicati ons might be the most common cause of oral dryness in the elderly. A revie w of the lite rature confirms that clo se to 400 medic ations are associated with oral dryne ss. The se findin gs are supported by many studi es that suggest a statistical assoc iation betwe en saliv ary hypofunction and the number of medications a patient takes. Because the production of saliva is controlled by cholinerg ic innervation , it is reasonable to assume that anticholinergic drug s will prevent salivary flow . Therefore, a large numb er of medications could be respon sible for dryness, including antihi stamines, psychotrop ic agents and sedatives, antireflu x medicines, bell adonna and atropine drugs, and rauwolfia deri vative s. In addition , alph a adrenergic age nts and antih ypertensives such as beta blockers, calcium channel blockers, ang ioten sin-convertin g enzyme inh ibitors, and diuretics either affe ct sali vary output or aggravate oral dryness.
An 80-year-old white woman who -was takin g the tricyclic antidepress ant nortriptyline de veloped a derm atologic allergic reaction to an insect bite. In respon se to the reaction, she took diphenhydramine. One day later, the woman requ ested a consultation with her geriatrician, compl aining of glossodyni a and mouth dryness. Examination reve aled a rash around the area of the insect bite. Her oral mucosa was dry, and there were very prominent papillae on her tongu e.
The geriatrician discontinued nortriptyline and prescribed the selective serotonin reuptake inhibitor sert raline, which has less of a drying effect. The diphenhydramine was also discont inued, and the patient was advised to use a local steroid cream instead. During a telephone followup , the wom an reported relief of the acute oral symptoms, which were theoretically cau sed by or exac erbated by two drugs that have additive mouth-drying propertie s. In this case, the most appropriate therapy was to discont inue the offending agents.
Case 2: Systemic disease. Systemic illnes s and stress also contribute signi ficantly to the prevalence of xerostomia among the elderl y. Mouth dryne ss can occur in common illnesses such as anxiety, depression, dehydration , hypothyroidism , diabetes mellitus or insipidus, nephritis, and Sjog ren ' s disease and dur ing menopau se . It is also well documented in post-irradiated patient s who have been treated for head and neck cancer.
Sjo gren ' s syndrome is an autoimmune disorder that prim aril y targets the lacrim al and salivary glands. Primary Sjo gren ' s syndrome occurs alon e, while secondary Sjog ren ' s is associ ated with a concomitant specific connective tissue disease." The histop ath ology of Sj ogren ' s characteri stically rev eal s a lymphocytic infiltration of the saliv ary glands and their acini. Its manifestations typically include xerostomi a and keratoconjuncti vitis sicca.
A 76-ye ar-old white woman with recurrent eye infection s, multiple joint pain s, and a rec ent maculopapular skin rash had complained to her primary care ph ysici an about mouth dryness, a complaint that she said had been ignored. After referral, an oto rhin ologic evaluation revealed an extremel y dry , erythe matous buccal mucosa and conjunctival erythema. The wom an was referred to a geriatrician, wh o confirmed the presence of keratoconjunctivitis sicca with a Schirmer' s test and Sjogren ' s disea se with an antibody test. A skin biopsy performed by a dermatologi st rev ealed a probable vasculitis. A saliva ry gland biopsy revealed lymphocytic infiltration, confirming the dia gnosis of Sjogren ' s di sea se. As part of her therapy, the woman was treated with a sialag og ue, consisting of a mouthwash diluted with lemon concentrate in water 1:4 three times a day and with artificial saliva. The use of pilocarpine HCI , although controversial, might hav e improved her chronic oral dryness.
Case 3: Radiation therapy. Slightly more than 40,000 new case s of head and neck ca ncer ar e diagnosed annually in the Un ited States." :" Up to 60 % of pati ents undergo radiotherapy , either as a cure or as an adjunct to treatment. Xerostomia is a uni versally recognized condition following radiation therapy. Radiotherapy affects salivary gland parenchym a, which leads initi ally to inflammation and ultimately to atrophy, fib rosis, and subsequent hyposecreti on. Drei zen et al showed that radiation cau ses a progressiv e decrease in salivary flow be ginning during the first week of treatm ent.' ? Aft er 3 years, the percentage of de crease exceeds 90 % and is presumabl y permanent.
W e examined an 80-year-old white man with a hi story of squamous cell carcinoma of the nasopharynx who had been treated with full-course radi ation therapy approximately 4 months earlier. Th e pati ent also had a history of anxiety disorder, insomnia, diabetes mell itus, and slee p apnea. Dry mouth had become a major discomfort since his oral radi ati on . Th e patient' s sleep apnea, which was associated with mouth breathing and snoring, had also contributed to the xeros tomia. An otorhinologic evaluation rev ealed that the oral and buccal mucosa were indeed dry. Examination and testin g also reveal ed mucositi s, but no salivary gl and disease, duct stones, or fun gemia. No ob viou s na sopharyngeal tumor was not ed . Th e pat ient was adv ised to use a loc al sialag og ue, artificial saliva, and pilocarpine, which led to'some improvement. He was also instru cted to use a nasal continuous positive airway pre ssure (C-PAP) apparatus with humidifier. On followup , the patient reported that his mouth dryness was more tolerable. Starting pil ocarpine, ideally while the patient is 478 bein g radi ated , ca n prev ent complication s associated with chronic muc ositi s.
Dental complications of xerostomia
Oral dryne ss can lead to complications and significa nt morbid ity . Sali vary hypofunction can alter the oral flor a and contribute to plaqu e formation , ther eb y increasing the risk for oppo rtunistic infections (e .g., Candida albicans infection) and the proliferat ion of cariog enic microorganis ms (e.g., Streptococcus mutan s and Lactobacillu s Spp.).IJ.l.1 Or al dryn ess can induce lower pH values, alter the elec trolyte balance , and decrea se secretory IgA , thereby wea kening the dentition ' s defense aga inst caries . Patients oft en present with mouth or ton gu e burning, bacteri al or fungal infections of the oral muco sa and teeth, glo ssitis with fissuring of the ton gue , cracke d lip s, halit osis, parotitis , ging ivitis, and difficulty speaking and swallowing. Poor oral health can lead to tooth loss and malnutrition.
Bill ing s documented the prevalence of coronal caries, root surface caries, abras ion, and ero sion with de creased saliva ry flow ." Papas et al found that saliva-via its lubricating, remineralizing, ant ibacterial , and buffering actions-is an important fact or for the ma intenance of dentition and as sociated soft tissue ." Th eir study showed that xe ros tomia increa ses the risk of coronal and root di sease.
Laboratory and diagnostic tests
Penn ec et al studied the practical usefulness of combinations of te st s-includin g the sa livary flow rate , sialoche mistry, sialography, scintigraphy, and minor salivary gland biopsy-in Sjo gren ' s patients. " They concluded that among the most efficie nt combinations of tests were lower lip biopsy and saliv ary flow rate. They also concluded that scintigraphy provided a function al analysis of all of the salivary gla nds that correlat ed with parotid flow rate and with histopathologic changes of the gland, altho ug h it was not specific for Sjogren ' s disea se.
Treatmen t
Th e treatment of xero stomia is a ch all en ge . Siala gogue s and lubricating agent s stimulate and moi sturize. Histor ically, artificial salivas have been used to alle viate the dryness and muc ositis brou ght on by radiotherapy. Mucin-containing lozenge s have been recommended for the treatment of Sj ogren ' s xe rostomia, '? and lozen ges and ch ew ing gum seem to stimulate moderate salivary flow in rheumatic patients with dryne ss. IS Recentl y, pilocarpine has been used in the treatment of post-radiotherapy xeros tomia. It is also bein g investigated for use during earl y radiotherap y and in Sjogren ' s patients. Pilocarpin e is a naturally occurring alkaloid with cholinergic prop erties that acts as an agoni st at mu scarinic ENT-Ear, Nose & Throat Journal" July 1999 recept ors. Davies and Singer compared the use of a mucin-based artificial saliva and a pilocarpine mouthwash in the treatment of radiation-induced xerostomia." That prospective, randomized, crossover study of 20 patients revealed that the pilocarpine mouthwash was more effective in relieving symptoms. John son et al studied 207 patients and concluded that pilocarpine improved saliva production and relieved the symptoms of xerostomia; side effects were mild and limited to sweating." The major contra indications to pilocarpine therapy are uncontrolled asthma and certain types of glaucoma.
In summary, it is important for the otolaryngologist who treats patients with oral dryne ss to perform a complete examination and take a thorough history. The clinician should be cognizant of the illnesses and medications that are associated with dryness . The salivary flow test, sialography, and scintigraphy are sensitive tools that detect decreased sali vary output, althou gh they are not specific for Sjogren 's disease. The diagno sis of Sjogren's disease should be based on speci fic serology, an ophthalmologic consultation, and a lower lip biopsy . Patients who undergo radiotherapy of the head and neck should be treated prospectively for xerostomia, because it is an inevitable sequela to radiation. Mo st of the complications associated with xerostomia are caused by the breakdown of the normal funct ions of saliva , which include lubrication, digestion, and homeostasis. Patients should be treated for opportunistic oral infect ions in light of the replacement of normal oral flora with cariogenic bacteria and candidiasis. Appropriate dental hygiene and care will prevent losse s due to dental disease and gingi vitis.
